1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Wisconsin >
  6. Royal FrieslandCampina N.V. Acquires Wisconsin Whey Protein

M&A Deal Summary

Royal FrieslandCampina N.V. Acquires Wisconsin Whey Protein

On December 2, 2025, Royal FrieslandCampina N.V. acquired consumer products company Wisconsin Whey Protein

Acquisition Highlights
  • This is Royal FrieslandCampina N.V.’s 1st transaction in the Consumer Products sector.
  • This is Royal FrieslandCampina N.V.’s 2nd transaction in the United States.
  • This is Royal FrieslandCampina N.V.’s 1st transaction in Wisconsin.

M&A Deal Summary
Date 2025-12-02
Target Wisconsin Whey Protein
Sector Consumer Products
Buyer(s) Royal FrieslandCampina N.V.
Deal Type Add-on Acquisition

Target

Wisconsin Whey Protein

Darlington, Wisconsin, United States
Wisconsin Whey Protein is a U.S.-based dairy-ingredients manufacturer that produces whey-protein concentrates (WPC), whey-protein isolates (WPI), lactose, and cheeses. The Company serves customers in sectors such as infant formula, medical nutrition, health & wellness, sports nutrition, bakery, and food processing. Its operations include modern processing facilities in Darlington and Turtle Lake, Wisconsin.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Royal FrieslandCampina N.V.

Amersfoort, Netherlands
Category Company
Sector Food
DESCRIPTION

Royal FrieslandCampina N.V. produces and sells consumer products such as dairy-based beverages, infant nutrition, cheese and desserts in many European countries, in Asia and in Africa.

DEAL STATS #
Overall 3 of 3
Sector: Consumer Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Wisconsin M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-25 DFE Pharma

Goch, Germany

DFE Pharma is an excipient manufacturer. Excipients are the inactive substances that are blended with the active ingredients in medicine for purposes such as binding, bulking, disintegration or to aid in the processing of the active ingredient. With operations in Europe, India and New Zealand and an active presence in over 100 countries, DFE develops, produces and markets excipients primarily for oral solid dose and dry powder inhalation. DFE Pharma is based in Goch, Germany.

Buy -
Mergr

Solution for

Product

Company

Legal